DK1173548T3 - Materialer og fremgangsmåder til frembringelse af dopaminerge neuroner - Google Patents

Materialer og fremgangsmåder til frembringelse af dopaminerge neuroner

Info

Publication number
DK1173548T3
DK1173548T3 DK00929454T DK00929454T DK1173548T3 DK 1173548 T3 DK1173548 T3 DK 1173548T3 DK 00929454 T DK00929454 T DK 00929454T DK 00929454 T DK00929454 T DK 00929454T DK 1173548 T3 DK1173548 T3 DK 1173548T3
Authority
DK
Denmark
Prior art keywords
cells
neural
nurr1
neural stem
cell
Prior art date
Application number
DK00929454T
Other languages
Danish (da)
English (en)
Inventor
Ernest Arenas
Thomas Perlmann
Evan Y Snyder
Joseph Wagner
Peter Akerud
Original Assignee
Neuro Therapeutics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuro Therapeutics Ab filed Critical Neuro Therapeutics Ab
Application granted granted Critical
Publication of DK1173548T3 publication Critical patent/DK1173548T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0619Neurons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/385Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60Transcription factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/08Coculture with; Conditioned medium produced by cells of the nervous system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DK00929454T 1999-05-03 2000-04-27 Materialer og fremgangsmåder til frembringelse af dopaminerge neuroner DK1173548T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13231799P 1999-05-03 1999-05-03
PCT/EP2000/003842 WO2000066713A2 (fr) 1999-05-03 2000-04-27 Materiaux et procedes lies au developpement neuronal

Publications (1)

Publication Number Publication Date
DK1173548T3 true DK1173548T3 (da) 2007-10-08

Family

ID=22453462

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00929454T DK1173548T3 (da) 1999-05-03 2000-04-27 Materialer og fremgangsmåder til frembringelse af dopaminerge neuroner

Country Status (10)

Country Link
US (1) US7465582B1 (fr)
EP (1) EP1173548B1 (fr)
JP (1) JP2002542818A (fr)
AT (1) ATE364688T1 (fr)
AU (1) AU4752700A (fr)
CA (1) CA2371260A1 (fr)
DE (1) DE60035191T2 (fr)
DK (1) DK1173548T3 (fr)
ES (1) ES2290032T3 (fr)
WO (1) WO2000066713A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129034B2 (en) 2001-10-25 2006-10-31 Cedars-Sinai Medical Center Differentiation of whole bone marrow
JP2005507927A (ja) * 2001-10-30 2005-03-24 バイオジェン・アイデック・エムエイ・インコーポレイテッド パーキンソン病を処置するための方法および組成物
EP1511839A4 (fr) * 2002-06-05 2005-11-16 Es Cell Int Pte Ltd Generation de cellules souches neurales provenant de cellules souches embryonnaires humaines non differenciees
US20060233771A1 (en) * 2002-09-24 2006-10-19 Ernesto Arenas Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands
KR20040079669A (ko) * 2003-03-10 2004-09-16 학교법인 한양학원 Nurr1 과발현에 의한 도파민성 신경세포의 분화방법
WO2005003320A2 (fr) * 2003-07-02 2005-01-13 Regents Of The University Of Minnesota Differenciation neuronale de cellules souches
EP1779867A4 (fr) * 2004-07-01 2009-12-02 Eisai R&D Man Co Ltd Promoteur de la régénérescence nerveuse
WO2007119180A2 (fr) * 2006-04-07 2007-10-25 Neuro Therapeutics Ab Survie et développement de cellules nerveuses
EP1897937A1 (fr) * 2006-09-07 2008-03-12 NeuroProgen GmbH Leipzig Méthode de culture de cellules neuronales progénitrices
CA2700573C (fr) 2006-09-26 2016-11-22 Cedars-Sinai Medical Center Vaccins comprenant des antigenes de cellules souches cancereuses et procedes
CA2700436C (fr) 2006-09-28 2017-04-18 John S. Yu Vaccins contre le cancer et methodes de vaccination
PL2328923T3 (pl) 2008-09-02 2016-06-30 Cedars Sinai Medical Center Epitopy CD133
KR101181423B1 (ko) * 2009-01-30 2012-09-19 한양대학교 산학협력단 Nurr1 변이체 발현을 이용한 개선된 도파민 신경세포의유도방법
EP2427485B1 (fr) 2009-05-07 2016-12-07 ImmunoCellular Therapeutics, Ltd. Epitopes des cd133
KR101358601B1 (ko) 2011-12-30 2014-02-05 한양대학교 산학협력단 도파민 뉴런의 제조 방법
ES2662333T3 (es) 2013-02-14 2018-04-06 Immunocellular Therapeutics Ltd. Vacunas contra el cáncer y métodos de vacunación
JP6340216B2 (ja) 2014-03-07 2018-06-06 株式会社日立ハイテクノロジーズ 走査電子顕微鏡
KR102203034B1 (ko) * 2017-11-06 2021-01-14 한양대학교 산학협력단 중뇌 유래의 성상교세포와 도파민 신경줄기세포의 공동 이식에 의한 도파민 신경세포의 이식 치료 효과 개선
JP2019106895A (ja) * 2017-12-15 2019-07-04 インダストリー‐ユニバーシティー コーぺレーション ファンデーション ハンヤン ユニバーシティ 神経幹細胞または神経前駆細胞からドーパミン神経細胞への分化方法
CN111484977B (zh) * 2019-01-25 2023-05-16 中国科学院脑科学与智能技术卓越创新中心 重编程产生功能性去甲肾上腺素能神经元的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981165A (en) * 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. In vitro induction of dopaminergic cells
ES2167461T3 (es) 1994-09-23 2002-05-16 Neurospheres Holdings Ltd Modelos in vitro de funcion y disfuncion del sistema nervioso central.
US6284539B1 (en) * 1998-10-09 2001-09-04 Neuralstem Biopharmaceuticals, Ltd. Method for generating dopaminergic cells derived from neural precursors
US6312949B1 (en) 1999-03-26 2001-11-06 The Salk Institute For Biological Studies Regulation of tyrosine hydroxylase expression
WO2001088104A2 (fr) 2000-05-17 2001-11-22 Geron Corporation Populations de progeniteurs neuronaux
US20020114788A1 (en) 2000-07-27 2002-08-22 Ole Isacson Cell implantation therapy for neurological diseases or disorders

Also Published As

Publication number Publication date
EP1173548B1 (fr) 2007-06-13
AU4752700A (en) 2000-11-17
DE60035191T2 (de) 2008-06-19
CA2371260A1 (fr) 2000-11-09
US7465582B1 (en) 2008-12-16
ES2290032T3 (es) 2008-02-16
JP2002542818A (ja) 2002-12-17
WO2000066713A2 (fr) 2000-11-09
DE60035191D1 (de) 2007-07-26
WO2000066713A3 (fr) 2001-04-05
EP1173548A2 (fr) 2002-01-23
ATE364688T1 (de) 2007-07-15

Similar Documents

Publication Publication Date Title
DK1173548T3 (da) Materialer og fremgangsmåder til frembringelse af dopaminerge neuroner
Tepper et al. Heterogeneity and diversity of striatal GABAergic interneurons: update 2018
Schubert et al. Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling
Villanueva et al. The role of thyroid hormones as inductors of oxidative stress and neurodegeneration
Lennington et al. Neural stem cells and the regulation of adult neurogenesis
Burrows et al. Genealogy of the anterior pituitary gland: tracing a family tree
Hitoshi et al. Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress
Garcia-Segura Hormones and brain plasticity
Liu et al. Hydrostatic pressures promote initial osteodifferentiation with ERK1/2 not p38 MAPK signaling involved
Farzanehfar Comparative review of adult midbrain and striatum neurogenesis with classical neurogenesis
Ma et al. Induction of FOS expression by acute immobilization stress is reduced in locus coeruleus and medial amygdala of Wistar–Kyoto rats compared to Sprague–Dawley rats
Valentino et al. Molecular and cellular sex differences at the intersection of stress and arousal
Domínguez‐López et al. Electrophysiological characterization of dopamine neuronal activity in the ventral tegmental area across the light–dark cycle
Congiu et al. Opposite responses to aversive stimuli in lateral habenula neurons
Cruce A supraspinal monosynaptic input to hindlimb motoneurons in lumbar spinal cord of the frog, Rana catesbiana.
Yorgason et al. Frequency‐dependent effects of ethanol on dopamine release in the nucleus accumbens
Hoefflin et al. Neuronal expression of SOX2 is enriched in specific hypothalamic cell groups
SAITO et al. Potentiation of the NGF-mediated nerve fiber outgrowth by ginsenoside RB, in organ cultures of chicken dorsal root ganglia
DE60026703D1 (de) Vorrichtung zur messung und detektion von acetylen gelösst in einem fluid
Guyon et al. Stromal‐cell‐derived factor 1α/CXCL12 modulates high‐threshold calcium currents in rat substantia nigra
Fraser Exorcism rituals: Effects on multiple personality disorder patients.
Reh et al. Understanding individual variation in levels of second language attainment through the lens of critical period mechanisms
Feduccia et al. Theropod-bird link reconsidered
Kraus et al. Influence of the hippocampus on amino acid utilizing and cholinergic neurons within the nucleus accumbens is promoted by histamine via H 1 receptors
Dreifuss et al. Electrophysiology of vasopressin in normal rats and in rats of the Brattleboro strain.